Literature DB >> 29182164

Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.

Alexander Drilon, Zishuo I Hu, Gillianne G Y Lai, Daniel S W Tan.   

Abstract

This corrects the article DOI: 10.1038/nrclinonc.2017.175.

Entities:  

Year:  2017        PMID： 29182164     DOI： 10.1038/nrclinonc.2017.188

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


  12 in total

1.  High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden.

Authors:  Ryma Benayed; Michael Offin; Kerry Mullaney; Purvil Sukhadia; Kelly Rios; Patrice Desmeules; Ryan Ptashkin; Helen Won; Jason Chang; Darragh Halpenny; Alison M Schram; Charles M Rudin; David M Hyman; Maria E Arcila; Michael F Berger; Ahmet Zehir; Mark G Kris; Alexander Drilon; Marc Ladanyi
Journal:  Clin Cancer Res       Date:  2019-04-26       Impact factor: 12.531

2.  A critical ETV4/Twist1/Vimentin axis in Ha-RAS-induced aggressive breast cancer.

Authors:  Wuling Liu; Babu Gajendran; Klarke M Sample; Chunlin Wang; Anling Hu; Beiling Chen; Yanmei Li; Eldad Zacksenhaus; Yaacov Ben-David
Journal:  Cancer Gene Ther       Date:  2022-04-27       Impact factor: 5.987

3.  Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes.

Authors:  Ana Carolina Pavanelli; Flavia Rotea Mangone; Piriya Yoganathan; Simone Aparecida Bessa; Suely Nonogaki; Cynthia A B de Toledo Osório; Victor Piana de Andrade; Iberê Cauduro Soares; Evandro Sobrosa de Mello; Lois M Mulligan; Maria Aparecida Nagai
Journal:  Breast Cancer Res Treat       Date:  2022-01-15       Impact factor: 4.872

4.  Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy.

Authors:  Or Kalchiem-Dekel; Christina J Falcon; Christine M Bestvina; Dazhi Liu; Lauren A Kaplanis; Clare Wilhelm; Jordan Eichholz; Guilherme Harada; Lori J Wirth; Subba R Digumarthy; Robert P Lee; David Kadosh; Robin B Mendelsohn; Jessica Donington; Justin F Gainor; Alexander Drilon; Jessica J Lin
Journal:  J Thorac Oncol       Date:  2022-07-02       Impact factor: 20.121

Review 5.  Advances in Targeting RET-Dependent Cancers.

Authors:  Vivek Subbiah; Gilbert J Cote
Journal:  Cancer Discov       Date:  2020-02-24       Impact factor: 39.397

Review 6.  Ret Receptor Has Distinct Alterations and Functions in Breast Cancer.

Authors:  Albana Gattelli; Nancy E Hynes; Ignacio E Schor; Sabrina A Vallone
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-02-21       Impact factor: 2.673

Review 7.  Translating Systems Medicine Into Clinical Practice: Examples From Pulmonary Medicine With Genetic Disorders, Infections, Inflammations, Cancer Genesis, and Treatment Implication of Molecular Alterations in Non-small-cell Lung Cancers and Personalized Medicine.

Authors:  Julian Pinsolle; Anne McLeer-Florin; Matteo Giaj Levra; Florence de Fraipont; Camille Emprou; Elisa Gobbini; Anne-Claire Toffart
Journal:  Front Med (Lausanne)       Date:  2019-10-29

8.  Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

Authors:  P Garrido; E Conde; J de Castro; J J Gómez-Román; E Felip; L Pijuan; D Isla; J Sanz; L Paz-Ares; F López-Ríos
Journal:  Clin Transl Oncol       Date:  2019-10-09       Impact factor: 3.405

9.  NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake.

Authors:  Young Ah Lee; Hyunjung Lee; Sun-Wha Im; Young Shin Song; Do-Youn Oh; Hyoung Jin Kang; Jae-Kyung Won; Kyeong Cheon Jung; Dohee Kwon; Eun-Jae Chung; J Hun Hah; Jin Chul Paeng; Ji-Hoon Kim; Jaeyong Choi; Ok-Hee Kim; Ji Min Oh; Byeong-Cheol Ahn; Lori J Wirth; Choong Ho Shin; Jong-Il Kim; Young Joo Park
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 14.808

Review 10.  Influencers on Thyroid Cancer Onset: Molecular Genetic Basis.

Authors:  Berta Luzón-Toro; Raquel María Fernández; Leticia Villalba-Benito; Ana Torroglosa; Guillermo Antiñolo; Salud Borrego
Journal:  Genes (Basel)       Date:  2019-11-08       Impact factor: 4.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.